Verona Pharma Plc - ADR
XNAS: VRNA
Verona Pharma Plc - ADR Live Share Price Today, Share Analysis and Chart
about
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrin...
Read More
104.83
-0.02
(-0.02%)
10.9M
XNAS Volume
High vol.+gain this week
XNAS 11 Jul, 2025 5:30 PM (EDT)
Analyst Downgrade
Wells Fargo downgrades Verona Pharma to 'Equalweight'; cuts the target price to $107
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Verona Pharma Plc - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..